[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Ji J, Shen I, Li Y, Liu Y, et al. Oncol Rep 2023;50:165.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ji J, Shen I, Li Y, Liu Y, et al. [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Oncol Rep 2023;50:165.
PMID: 37477123